Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00029692 · ClinicalTrials.gov registry record · Phase 2

Effects of Ginseng and Ginkgo on Drug Disposition in Man

A Phase 2 study of Healthy, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
Phase 2
Development phase
60
Enrollment target
1
Study location

NCT00029692 is a Phase 2 study of Healthy that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 60 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00029692, a Phase 2 study of Healthy, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will assess the effects of ginseng and ginkgo on 1) cognitive function, 2) enzymes that process drugs, and 3) enzymes that may help prevent cancer.

Conditions Studied

Healthy

Interventions

  • DRUG Ginseng
  • DRUG Ginkgo

Study Locations (1)

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2002-03
Est. Completion 2005-03
Phase Phase 2

Sponsor

National Center for Complementary and Integrative Health (NCCIH)

203 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00029692

The ClinicalTrials.gov registry entry for NCT00029692 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (91% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Ginseng is the first listed.

NCT00029692 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT00029692 about?

NCT00029692 is a clinical study titled "Effects of Ginseng and Ginkgo on Drug Disposition in Man". This study will assess the effects of ginseng and ginkgo on 1) cognitive function, 2) enzymes that process drugs, and 3) enzymes that may help prevent cancer.

What is the current status of trial NCT00029692?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2002-03. Estimated completion is 2005-03.

What conditions does trial NCT00029692 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00029692?

The interventions under investigation include: Ginseng (DRUG), Ginkgo (DRUG).

Who is sponsoring clinical trial NCT00029692?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00029692 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Kansas

All trials with a study site in Kansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.